<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-26T11:31:54+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>祝贺！2020年中国国家药监局(NMPA)“官宣”批准的13款创新药</title>
    <updated>2020-12-26T09:31:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/JfwlV8NtfOE398ETZkzFwg</id>
    <link href="https://mp.weixin.qq.com/s/JfwlV8NtfOE398ETZkzFwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>原创 | 如何让免疫疗法惠及更多患者？靶向自噬通路或许是个好方向</title>
    <updated>2020-12-26T09:31:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/3f2rLeYjVBGrNzpWgnpR7A</id>
    <link href="https://mp.weixin.qq.com/s/3f2rLeYjVBGrNzpWgnpR7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠治疗药物开发情况概览</title>
    <updated>2020-12-26T09:31:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/yqUx4LC1PBkQUoOzTOIYew</id>
    <link href="https://mp.weixin.qq.com/s/yqUx4LC1PBkQUoOzTOIYew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>hERG毒性与化合物的结构特征及优化策略</title>
    <updated>2020-12-26T09:31:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/JiTAf7OHwEohiD_ZIS_WJw</id>
    <link href="https://mp.weixin.qq.com/s/JiTAf7OHwEohiD_ZIS_WJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020，张江十大热点事件！</title>
    <updated>2020-12-26T09:31:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/9a7kFdkHWuyW24CM-K-98g</id>
    <link href="https://mp.weixin.qq.com/s/9a7kFdkHWuyW24CM-K-98g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>22亿美元合作达成，Vertex携手Skyhawk共同开发可调节RNA剪接的新型小分子药物</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/FKQpfaxMZDlQh-1ROhEkRQ</id>
    <link href="https://mp.weixin.qq.com/s/FKQpfaxMZDlQh-1ROhEkRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国生物技术发展中心副主任孙燕荣接受纪律审查和监察调查</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/93NCR3y33RuYyxN-BrfIpQ</id>
    <link href="https://mp.weixin.qq.com/s/93NCR3y33RuYyxN-BrfIpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济、再鼎、康方纷纷加入，胃癌药物竞争格局不断重塑</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/kryDKXyD8fL4B9Q4EISAxA</id>
    <link href="https://mp.weixin.qq.com/s/kryDKXyD8fL4B9Q4EISAxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投资超20家！高瓴在张江设立创新中心啦！</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/Exdb_Ev5dd0xpAvOXtXVcQ</id>
    <link href="https://mp.weixin.qq.com/s/Exdb_Ev5dd0xpAvOXtXVcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甘莱制药ASC41完成Ib期临床试验超重和肥胖受试者给药</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/P5zEJmSvCmk3ny-LNL9BMg</id>
    <link href="https://mp.weixin.qq.com/s/P5zEJmSvCmk3ny-LNL9BMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官宣！前武田业务负责人陆义骏先生出任北海康成中国区总经理</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/EpC7NVCsBXm8gMgMOFlScg</id>
    <link href="https://mp.weixin.qq.com/s/EpC7NVCsBXm8gMgMOFlScg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>儿童罕见高危神经母细胞瘤：GD2单抗大显身手</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/3HTHgAofmOFE9WIc6b1KnQ</id>
    <link href="https://mp.weixin.qq.com/s/3HTHgAofmOFE9WIc6b1KnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>HAPPY WORKRISTMAS!</title>
    <updated>2020-12-25T00:01:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/vZKMDW9WXGMjCyr7bO5A_A</id>
    <link href="https://mp.weixin.qq.com/s/vZKMDW9WXGMjCyr7bO5A_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Tezepelumab错过重度哮喘III期临床试验主要终点，为其市场前景添上一道阴影</title>
    <updated>2020-12-24T08:05:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/jFVnZl1Y4l5NwrA-LpAUDg</id>
    <link href="https://mp.weixin.qq.com/s/jFVnZl1Y4l5NwrA-LpAUDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海有机所“时间调控手性反转”研究工作入选2020年度C&amp;amp;EN三项轰动性合成工作之一</title>
    <updated>2020-12-24T08:05:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/VeOAMlsnTlNmctwR4y4BAA</id>
    <link href="https://mp.weixin.qq.com/s/VeOAMlsnTlNmctwR4y4BAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>预测 | 2021年最具商业潜力的上市新药TOP10</title>
    <updated>2020-12-24T08:05:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/0kufxTjyNCXj_Fmm0QbZug</id>
    <link href="https://mp.weixin.qq.com/s/0kufxTjyNCXj_Fmm0QbZug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局长三角、大湾区四个审评检查分中心挂牌成立</title>
    <updated>2020-12-24T08:05:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/EYnGxDmuNir2CTq6cNWftw</id>
    <link href="https://mp.weixin.qq.com/s/EYnGxDmuNir2CTq6cNWftw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾药时代直播间 | 流体化学技术在制药CDMO应用的特色及案例分享</title>
    <updated>2020-12-24T08:05:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/u1VEVtIkqcMxSd99oeLEhw</id>
    <link href="https://mp.weixin.qq.com/s/u1VEVtIkqcMxSd99oeLEhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>真实世界中的度伐利尤单抗：III期NSCLC根治性放化疗后的巩固效果</title>
    <updated>2020-12-24T08:05:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/1SmPCLbaqxcDJlsLAJwbDQ</id>
    <link href="https://mp.weixin.qq.com/s/1SmPCLbaqxcDJlsLAJwbDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>艾德生物与德国默克达成中国市场的伴随诊断战略合作</title>
    <updated>2020-12-24T08:05:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/xjXzOuV7rMV6As85x_znqQ</id>
    <link href="https://mp.weixin.qq.com/s/xjXzOuV7rMV6As85x_znqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>